Welcome to Shelston IP’s round-up of the best patent cases from Australia delivered during 2017.
There were significant and interesting decisions from appeals to the Full Federal Court, from Federal Court trials and interlocutory applications for injunctions and various other orders, and from the Australian Patent Office. Several decisions related to issues that had not been judicially considered for quite some time. There was a landmark damages award in a pharmaceutical case, important decisions regarding damages for unjustified threats, a preliminary discovery application in a biosimilar case, important decisions on issues of infringement and renewed efforts by pharmaceutical patentees in seeking interlocutory injunctions.
The Snapshots section is designed to assist readers in navigating this publication and identifying cases of particular interest.
Please click here to access the report and do not hesitate to contact any of the authors if you are interested in learning more.
Authored by Duncan Longstaff